REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $607,890 | +16.5% | 50,322 | +2.1% | 0.00% | – |
Q2 2023 | $521,637 | -15.7% | 49,304 | -21.6% | 0.00% | – |
Q1 2023 | $618,966 | -44.6% | 62,903 | -17.2% | 0.00% | – |
Q4 2022 | $1,117,768 | -37.4% | 75,987 | -48.4% | 0.00% | – |
Q3 2022 | $1,786,000 | -13.5% | 147,257 | -0.3% | 0.00% | – |
Q2 2022 | $2,065,000 | +75.0% | 147,691 | +78.0% | 0.00% | – |
Q1 2022 | $1,180,000 | +60.3% | 82,981 | +137.8% | 0.00% | – |
Q4 2021 | $736,000 | -67.9% | 34,890 | -60.1% | 0.00% | – |
Q3 2021 | $2,292,000 | -44.6% | 87,352 | -34.2% | 0.00% | -100.0% |
Q2 2021 | $4,138,000 | +115.3% | 132,728 | +112.0% | 0.00% | – |
Q1 2021 | $1,922,000 | +44.4% | 62,616 | +61.4% | 0.00% | – |
Q4 2020 | $1,331,000 | +100.8% | 38,796 | +80.2% | 0.00% | – |
Q3 2020 | $663,000 | +72.2% | 21,535 | +73.4% | 0.00% | – |
Q2 2020 | $385,000 | – | 12,421 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |